4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-22-062169
CIK 0001539029other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:38 PM ET
Size
6.9 KB
Accession
0001209191-22-062169
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2022-12-20−23,636→ 0 totalExercise: $0.40Exp: 2023-02-28→ Common Stock (23,636 underlying) - Exercise/Conversion
Common Stock
2022-12-20$0.40/sh+23,636$9,454→ 377,502 total
Footnotes (1)
- [F1]Fully vested and exercisable.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 4:38 PM ET
- Size
- 6.9 KB